1. In this decision analysis model, population screening for three common hereditary conditions was cost-effective in adults younger than 40. 2. Population genomic screening was particularly cost-effective if probands had access to preventative care. Evidence Rating Level: 1 (Excellent) Study Rundown: Population genomic screening for Lynch Syndrome (LS), hereditary breast and ovarian cancer syndrome (HBOC),
Population Genomic Screening for 3 Conditions Likely Cost-Effective renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.